T. Rowe Price Associates’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Buy |
+43,525
| New | +$221K | ﹤0.01% | 2666 |
|
|
2021
Q4 | – | Sell |
-12,024
| Closed | -$109K | – | 3041 |
|
|
2021
Q3 | $109K | Buy |
+12,024
| New | +$109K | ﹤0.01% | 2822 |
|
|
2016
Q2 | – | Sell |
-37,175
| Closed | -$2.05M | – | 2535 |
|
|
2016
Q1 | $2.05M | Sell |
37,175
-46,326
| -55% | -$2.56M | ﹤0.01% | 1514 |
|
|
2015
Q4 | $11.5M | Sell |
83,501
-1,078
| -1% | -$148K | ﹤0.01% | 1249 |
|
|
2015
Q3 | $11.8M | Sell |
84,579
-424
| -0.5% | -$59K | ﹤0.01% | 1265 |
|
|
2015
Q2 | $21.4M | Buy |
+85,003
| New | +$21.4M | ﹤0.01% | 1117 |
|